Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 20,918 shares at $6.14 ($129K) on 2026-06-09, disclosed to the SEC on 2026-06-11.
Open-market sale of $129k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.14 | 14,500 | $89K | 69.1% |
| 2 | $6.21 | 6,418 | $40K | 30.9% |
| Total | $6.16 avg | 20,918 | $129K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |
| GYRE | SELL | 2026-05-22 | $137K | — | Filing → |